“Evaluation the Serum Levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in Patients With Benign and Malignant Thyroid Tumors”. Journal of Pharmaceutical Negative Results, vol. 13, no. 3, Sept. 2022, pp. 559-71, https://doi.org/10.47750/pnr.2022.13.03.085.